Delivery Order SPE2DB22D2007-SPE2DB25FJ2BP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,097.65 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Eliquis 2.5 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.00 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on August 12, 2025, with completion scheduled for August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,259.49 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,533.97 for 60 tablets of Eliquis 5 mg on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on July 29, 2025, with completion targeted for July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,932.82 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, with an ultimate completion date of June 2, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a pharmaceutical supply fulfillment under AmerisourceBergen's existing contract vehicle with the agency. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,896.80 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 26, 2025, represents a non-competitive award with an ultimate completion date of August 27, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $3,076.98 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets in unit-dose packaging (100 count). This firm fixed-price, non-set-aside contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,719.90 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg on July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2BPDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,652.64 for 60 tablets of Eliquis 2.5 mg on June 4, 2025, with completion expected by June 5, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procurement procedures. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is a child contract executed under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's substantial federal contract portfolio and demonstrated capability to fulfill requirements through open competition have established it as a critical vendor within the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 6/4/25 |